The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-line icotinib versus cisplatine/pemetrexed plus pemetrexed maintenance therapy in lung adenocarcinoma patients with sensitizing EGFR mutation (CONVINCE).
 
Yuankai Shi
No Relationships to Disclose
 
Lin Wang
No Relationships to Disclose
 
Baohui Han
No Relationships to Disclose
 
Wei Li
No Relationships to Disclose
 
Ping Yu
No Relationships to Disclose
 
Yunpeng Liu
No Relationships to Disclose
 
Cuimin Ding
No Relationships to Disclose
 
Xia Song
No Relationships to Disclose
 
Ma Zhi Yong
No Relationships to Disclose
 
Xinling Ren
No Relationships to Disclose
 
Ji Feng Feng
No Relationships to Disclose
 
Helong Zhang
No Relationships to Disclose
 
Gongyan Chen
No Relationships to Disclose
 
Ning Wu
No Relationships to Disclose
 
Xiaohong Han
No Relationships to Disclose
 
Chen Yao
No Relationships to Disclose
 
Yong Song
No Relationships to Disclose
 
Shucai Zhang
No Relationships to Disclose
 
Lieming Ding
Employment - Betta Pharmaceuticals
 
Fenlai Tan
Employment - Betta Pharmaceuticals